USAQ

QHSLab, Inc. USAQ

USAQ
QHSLab, Inc. CYDX
CYduct Diagnostics, Inc. IRME
IR-Med Inc. NUMD
Nu-Med Plus, Inc. TBRIF
Therma Bright Inc. RGBP
Regen BioPharma, Inc. TLIS
Talis Biomedical Corporation MNFSF
ManifestSeven Holdings Corporation NRPR
Nutri Pharmaceuticals Research, Inc. MODVQ
ModivCare Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode USAQ CYDX IRME NUMD TBRIF RGBP TLIS MNFSF NRPR MODVQ
6M 40.60 % -1.04 % -78.97 % -55.43 % -54.57 % -73.05 % -5.63 % 24 900.00 % 0.00 % -90.00 %
YTD -19.94 % 31.49 % -94.09 % 103.26 % -75.27 % -77.54 % -11.18 % 24 900.00 % 31.25 % -99.19 %
1Y 23.92 % 42.65 % -94.84 % -28.11 % -80.38 % -94.26 % -10.65 % 24 900.00 % 31.25 % -99.31 %
3Y 33.76 % -50.26 % -97.66 % 20.00 % -83.74 % -99.67 % -85.06 % 150.00 % -38.42 % -99.89 %
5Y -67.84 % -75.00 % -98.25 % -96.88 % -91.99 % -95.50 % -99.64 % -99.31 % 110.00 % -99.91 %
10Y 7.75 % -96.00 % -98.25 % -94.80 % -74.98 % -99.99 % -99.64 % -99.14 % 223.08 % -99.80 %
From the beginning -13.80 % -100.00 % -98.25 % -95.84 % -74.98 % -99.99 % -99.64 % -99.14 % -99.97 % -99.28 %

Dividend